Jupiter Research Capital (Asia) Ltd’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
Other funds holding CMPX
Jupiter Research Capital (Asia) Ltd's CMPX Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd sold out of Compass Therapeutics (CMPX) in Q3 2026, closing a stake of 15,432 shares — an estimated $33.8K sold.
Jupiter Research Capital (Asia) Ltd first reported a position in CMPX in Q2 2026 and held it in 1 quarter. The position peaked at $33.8K in Q2 2026. 164 funds tracked by Wall St. Rank hold CMPX as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd reported no remaining Compass Therapeutics position as of Q3 2026 after selling out during the quarter.
- Jupiter Research Capital (Asia) Ltd sold 15,432 Compass Therapeutics shares in Q3 2026, an estimated $33.8K.
- Jupiter Research Capital (Asia) Ltd first reported a position in Compass Therapeutics in Q2 2026 and held it in 1 quarter.
- Jupiter Research Capital (Asia) Ltd's Compass Therapeutics position peaked at $33.8K in Q2 2026.
- 164 funds tracked by Wall St. Rank held Compass Therapeutics as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.